Johnson & Johnson

JNJ · NYSE

Johnson & Johnson reported FY2025 revenue of $94.2 billion, FY2025 net income of $26.8 billion and 2026 Q1 revenue of $24.1 billion. The thesis depends on pharma growth, medtech execution, litigation outcomes and cash conversion.

Follow Add to Watchlist Ask Question

NYSE JNJ Coverage Bootstrap Johnson & Johnson

Member workspace

Financials and workspace tools are for paid members.

Paid login unlocks company financials, filing timeline, peer comparison, scorecard, and discussion. Valuation remains admin-only while we finalize market-data licensing.